Charu V - Search Results

1

Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly.

Senecal FM, Yee L, Gabrail N, Charu V, Tomita D, Rossi G, Schwartzberg L. Senecal FM, et al. Among authors: charu v. Clin Breast Cancer. 2005 Dec;6(5):446-54. doi: 10.3816/cbc.2005.n.050. Clin Breast Cancer. 2005. PMID: 16381629 Clinical Trial.

2

A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer.

Schwartzberg LS, Yee LK, Senecal FM, Charu V, Tomita D, Wallace J, Rossi G. Schwartzberg LS, et al. Among authors: charu v. Oncologist. 2004;9(6):696-707. doi: 10.1634/theoncologist.9-6-696. Oncologist. 2004. PMID: 15561813 Free article. Clinical Trial.

3

Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.

Mirtsching B, Charu V, Vadhan-Raj S, Colowick AB, Rossi G, Tomita D, McGuire WP. Mirtsching B, et al. Among authors: charu v. Oncology (Williston Park). 2002 Oct;16(10 Suppl 11):31-6. Oncology (Williston Park). 2002. PMID: 12435171 Clinical Trial.

4

Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks.

Vadhan-Raj S, Mirtsching B, Charu V, Terry D, Rossi G, Tomita D, McGuire WP. Vadhan-Raj S, et al. Among authors: charu v. J Support Oncol. 2003 Jul-Aug;1(2):131-8. J Support Oncol. 2003. PMID: 15352656

5

Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: a controlled, randomized, open-label phase II trial.

Charu V, Belani CP, Gill AN, Bhatt M, Tomita D, Rossi G, Ben-Jacob A. Charu V, et al. Oncologist. 2007 Jun;12(6):727-37. doi: 10.1634/theoncologist.12-6-727. Oncologist. 2007. PMID: 17602062 Free article. Clinical Trial.

6

A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia.

Charu V, Saidman B, Ben-Jacob A, Justice GR, Maniam AS, Tomita D, Rossi G, Rearden T, Glaspy J. Charu V, et al. Oncologist. 2007 Oct;12(10):1253-63. doi: 10.1634/theoncologist.12-10-1253. Oncologist. 2007. PMID: 17962619 Free article. Clinical Trial.

7

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia.

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group. Hernandez E, et al. Among authors: charu v. Curr Med Res Opin. 2009 Sep;25(9):2109-20. doi: 10.1185/03007990903084164. Curr Med Res Opin. 2009. PMID: 19601709 Clinical Trial.

8

Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy.

Waltzman R, Croot C, Justice GR, Fesen MR, Charu V, Williams D. Waltzman R, et al. Among authors: charu v. Oncologist. 2005 Sep;10(8):642-50. doi: 10.1634/theoncologist.10-8-642. Oncologist. 2005. PMID: 16177289 Free article. Clinical Trial.

9

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study.

Boccia RV, Gordan LN, Clark G, Howell JD, Grunberg SM; Sancuso Study Group. Boccia RV, et al. Support Care Cancer. 2011 Oct;19(10):1609-17. doi: 10.1007/s00520-010-0990-y. Epub 2010 Sep 12. Support Care Cancer. 2011. PMID: 20835873 Free PMC article. Clinical Trial.

10

Initiation of epoetin-alpha therapy at a starting dose of 120,000 units once every 3 weeks in patients with cancer receiving chemotherapy: an open-label, multicenter study with randomized and nonrandomized treatment arms.

Glaspy JA, Charu V, Luo D, Moyo V, Kamin M, Wilhelm FE. Glaspy JA, et al. Among authors: charu v. Cancer. 2009 Mar 1;115(5):1121-31. doi: 10.1002/cncr.24127. Cancer. 2009. PMID: 19170225 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters